This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2jp5

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2jp5.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:2jp5.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2jp5| PDB=2jp5 | SCENE= }}
{{STRUCTURE_2jp5| PDB=2jp5 | SCENE= }}
-
'''ATWLPPR an anti-angiogenic peptide'''
+
===ATWLPPR an anti-angiogenic peptide===
-
==Overview==
+
<!--
-
Heptapeptide ATWLPPR (A7R), identified in our laboratory by screening a mutated phage library, was shown to bind specifically to neuropilin-1 (NRP-1) and then to selectively inhibit VEGF(165) binding to this receptor. In vivo, treatment with A7R resulted in decreasing breast cancer angiogenesis and growth. The present work is focused on structural characterization of A7R. Analogs of the peptide, obtained by substitution of each amino acid with alanine (alanine-scanning) or by amino acid deletion, have been systematically assayed to determine the relative importance of the side chains of each residue with respect to the inhibitory effect of A7R on VEGF(165) binding to NRP-1. We show here the importance of the C-terminal sequence LPPR and particularly the key role of C-terminal arginine. In solution, A7R displays significant secondary structure of the backbone adopting an extended conformation. However, the functional groups of arginine are very flexible in the absence of NRP-1 pointing to an induced fit upon binding to the receptor. A MD trajectory of the A7R/NRP-1 complex in explicit water, based on the recent tuftsin/NRP-1 crystal structure, has revealed the hydrogen-bonding network that contributes to A7R's binding activity.
+
The line below this paragraph, {{ABSTRACT_PUBMED_17983687}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 17983687 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_17983687}}
==About this Structure==
==About this Structure==
-
Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2JP5 OCA].
+
Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2JP5 OCA].
==Reference==
==Reference==
Line 25: Line 29:
[[Category: Peptide]]
[[Category: Peptide]]
[[Category: Protein binding inhibitor]]
[[Category: Protein binding inhibitor]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 09:08:21 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 03:38:44 2008''

Revision as of 00:38, 29 July 2008

Image:2jp5.png

Template:STRUCTURE 2jp5

ATWLPPR an anti-angiogenic peptide

Template:ABSTRACT PUBMED 17983687

About this Structure

Full experimental information is available from OCA.

Reference

Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex., Starzec A, Ladam P, Vassy R, Badache S, Bouchemal N, Navaza A, du Penhoat CH, Perret GY, Peptides. 2007 Dec;28(12):2397-402. Epub 2007 Sep 29. PMID:17983687

Page seeded by OCA on Tue Jul 29 03:38:44 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2jp5"
Personal tools